News

How Your Job Could Boost Your Memory

Jobs requiring intellectually challenging tasks may help preserve thinking skills and memory as workers age, according to a new study.

Prediabetes, Undiagnosed Diabetes Driving Up Care Costs

The cost of diabetes care in the United States has increased 48% in recent years, climbing to more than $322 billion annually.

AMA: Hospital Staff Should Consider Impact of CMS Rule

Hospital medical staff members need to consider the impact of a final rule issued by the Centers for Medicare & Medicaid Services (CMS) that revised the conditions of participation for hospitals and made two major changes to the hospital governance, according to an article published by the American Medical Association (AMA).

Cardiovascular Rx Adherence Boosted with Phone Reminders

A low-cost telephone reminder intervention can improve adherence to cardiovascular disease medications.

Drug Poisoning Deaths Quadruple, While Other Causes of Injury Deaths Down

A recent Mortality and Morbidity Weekly Report (MMWR) reported the death rates for the three most frequently occurring causes of injury death: drug poisoning, motor vehicle traffic, and firearm.

Obesity Costing the World $2 Trillion Annually

In a new McKinsey Global Institute discussion paper, obesity interventions from around the world are evaluated for evidence of overall impact in reducing the burden of health associated with this disease.

Triple Combination Therapy More Effective for Tension-Type Headache

Compared to acetaminophen monotherapy, the combination of acetylsalicylic acid, caffeine and acetaminophen is more effective in treating episodic tension-type headaches, says a new study.

Quinolone Use During Pregnancy: Is It Safe?

Quinolones and fluoroquinolones are effective broad-spectrum antibiotics that are used to treat numerous infections; however, concerns about possible teratogenic effects seen in animal studies have limited their use during pregnancy.

Can Garlic Prevent a Cold?

While this single trial alludes to garlic being potentially effective against the common cold, more studies will needed to be conducted to substantiate this finding.

How is Hysingla ER Different from Other Opioids?

The FDA has approved Hysingla ER (hydrocodone bitartrate; Purdue) extended-release tablets for the treatment of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.